Lululemon stock price target lowered to $180 by Bernstein on margin concerns

Bernstein cut its Lululemon price target to $180 from $205 and reduced fiscal 2026 EPS to $12.96 from $13.47; the stock trades at $159.27, near its 52-week low of $156.64 and is down ~51% over the past year. Lululemon reported Q4 FY2025 EPS of $5.01 (vs $4.79 est.) and revenue $3.6B (vs $3.58B est.), but management's 2026 guidance implies a low-single-digit U.S. sales decline and a ~250bps margin contraction driving a high-single-digit EPS decline. Other brokers also trimmed targets (Stifel $176 from $210; BTIG $225 from $260; Piper Sandler Neutral $190), and ongoing CEO search plus an activist position add near-term uncertainty.

Analysis

The market is pricing material execution risk into the equity — not just a temporary top-line wobble but a multi-quarter recovery assumption — which increases option value for both activism and management-driven restructurings. That creates two asymmetric channels: any credible acceleration in inventory-to-full-price sell-through will re-rate the stock sharply because fixed-cost operating leverage in the model amplifies incremental full-price margin recovery; conversely, a prolonged promotional environment will compound working-capital drag and force deeper margin compression through the P&L and the supply chain.

Second-order winners and losers are not the headline competitors but upstream and downstream players: contract manufacturers and fabric suppliers face demand cadence volatility (lumpy order timing can pressure lead times and input pricing), while premium leisurewear incumbents with healthier inventory turns can poach customer wallet share if the brand recovery stalls. Real estate owners and omnichannel logistics providers also see a timing mismatch — continued markdowning implies lower AURs and higher return rates, pressuring rent negotiations for mall-anchored locations and raising fulfillment cost per unit for high-return categories.

Key catalysts cluster by timeframe: near-term (days-weeks) — activist filings, interim CEO hires, or quarter-on-quarter inventory/sell-through prints; medium-term (3–12 months) — seasonal full-price sell-through trends and gross margin inflection; longer term (>12 months) — realization of restructuring/brand repositioning and whether the activist extracts capital allocation changes. Tail risks include activist failure to catalyze change, a management pivot that dilutes brand positioning, or macro-driven discretionary weakness that lengthens markdown cycles; upside reversal requires consistent sequential improvement in full-price demand and demonstrable inventory shrinkage faster than current guidance suggests.

Key Decisions for Investors

• Event-driven long (idiosyncratic recovery): Buy LULU equity sized 0.5–1.0% of portfolio with a 6–12 month horizon; pair with a 30–45 day protective put (cost <3% notional) to limit downside to ~20% while retaining >30% upside if full-price sell-through accelerates. R/R: asymmetric — pay small hedge premium to capture large re-rate if inventory normalizes.
• Pair trade to isolate brand risk: Go long LULU and short NKE in a 1:0.6 dollar-weighted ratio for 3–9 months to neutralize macro beta; target a positive idiosyncratic return of 25–40% if LULU recovers faster than category (stop-loss 15% adverse move on the pair).
• Options leveraged contrarian: Buy LULU 12–18 month LEAPS call (delta ~0.35) financed by selling 3–6 month out-of-the-money calls to cut carry; this expresses convex upside to a turnaround while generating premium to reduce net cost. R/R: limited cash outlay with multi-bucket upside if activist or CEO hire accelerates recovery.
• Short catalyst hedge (tactical): If management provides international/wholesale expansion language without proof points, initiate a short position using short-dated options or reducing long exposure (size 0.5% portfolio) given risk of margin dilution; exit on concrete KPIs (inventory turns, full-price mix) showing improvement within 90 days.